Product
Polyacrylamide gel electrophoresis
1 clinical trial
11 indications
Indication
Recurrent Salivary Gland CancerIndication
Laryngeal Squamous Cell CarcinomaIndication
Salivary Gland Squamous Cell CarcinomaIndication
Oral cancerClinical trial
A Phase I Dose Escalation Study of the mTOR Inhibitor Everolimus (RAD001) and Erlotinib Concurrently With Radiation Therapy in the Re-Irradiation Setting for Head and Neck CancerStatus: Withdrawn, Estimated PCD: 2011-05-01